AIDS. Promote HIV chemoprophylaxis research, don't prevent it.
Grant
Robert M
RM
Gladstone Institute of Virology and Immunology, San Francisco, CA, USA. rgrant@itsa.ucsf.edu
Buchbinder
Susan
S
Cates
Willard
W
Clarke
Edith
E
Coates
Thomas
T
Cohen
Myron S
MS
Delaney
Martin
M
Flores
Guiselly
G
Goicochea
Pedro
P
Gonsalves
Gregg
G
Harrington
Mark
M
Lama
Javier R
JR
MacQueen
Kathleen M
KM
Moore
John P
JP
Peterson
Leigh
L
Sanchez
Jorge
J
Thompson
Melanie
M
Wainberg
Mark A
MA
D000225:Adenine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000191:economics / Q000627:therapeutic use; D000349:Africa; D019380:Anti-HIV Agents / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D001208:Asia; D003256:Community Participation; D018849:Controlled Clinical Trials as Topic / Q000592:standards; D003376:Counseling; D003906:Developing Countries; D016527:Drug Costs; D005260:Female; D015658:HIV Infections / Q000517:prevention & control*; D006297:Health Services Accessibility; D006801:Humans; D007843:Latin America; D008297:Male; D063065:Organophosphonates / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D018579:Patient Selection; D000068698:Tenofovir
D019380:Anti-HIV Agents; D063065:Organophosphonates; D000068698:Tenofovir; D000225:Adenine